Health ❯ Patient Care

Treatment Innovations

Gene Therapy Neurological Disorders Drug Development Therapeutic Approaches Surgical Procedures Hospital Care Chemotherapy Cellular Therapies

Jazz Pharmaceuticals to Buy Actio Biosciences for $820 Million

The deal strengthens Jazz’s rare-epilepsy pipeline by adding ABS-1230, an oral precision therapy now in a Phase Ib/IIa registrational trial.

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

CAR T-Cell Therapy Yields Lasting Remission in Chronic Inflammatory Demyelinating Polyneuropathy

Lung-Targeted Nanoparticles Deliver Genetic Therapies to Treat Cancer and Cystic Fibrosis